Budapest, Hungary

Gyoergy Krasznai

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Nyilvanosan Muekoedoe. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyoergy Krasznai. Retrieved from https://idiyas.com/inventor/gyoergy-krasznai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gyoergy Krasznai: Innovator in Pharmaceutical Chemistry

Introduction

Gyoergy Krasznai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on improving treatments for diseases related to lipid metabolism.

Latest Patents

Krasznai holds a patent for the crystalline form I rosuvastatin zinc salt. This invention relates to a specific crystalline form of rosuvastatin zinc (2:1) salt, which is utilized as a pharmaceutically active ingredient. The patent outlines the method of preparation and its application in treating various lipid metabolism disorders, including hyperlipoproteinemia, hypercholesteremia, dyslipidemia, and atherosclerosis.

Career Highlights

Gyoergy Krasznai is associated with Egis Gyógyszergyár Nyilvánosan Működő. His work at this company has allowed him to focus on the development of pharmaceutical innovations that address critical health issues. His expertise in the field has positioned him as a valuable contributor to advancements in medical treatments.

Collaborations

Krasznai has collaborated with notable colleagues, including Ferenc Lorant Bartha and Gyoergyi Kovanyine Lax. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Gyoergy Krasznai's contributions to pharmaceutical chemistry, particularly through his patent on rosuvastatin zinc salt, highlight his role as an innovator in the field. His work continues to impact the treatment of lipid metabolism disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…